Effect of Teneligliptin versus Sulfonylurea on Major Adverse Cardiovascular Outcomes in People with Type 2 Diabetes Mellitus: A Real-World Study in Korea

BACKGROUND: Results regarding the cardiovascular (CV) effects of dipeptidyl peptidase-4 (DPP-4) inhibitors are inconsistent. This study aimed to assess the effects of teneligliptin, a DPP-4 inhibitor, on the risk of major CV outcomes in type 2 diabetes mellitus (T2DM) patients compared to sulfonylur...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Da Hea, Ha, Kyoung Hwa, Kim, So Hun, Kim, Dae Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937854/
https://www.ncbi.nlm.nih.gov/pubmed/33677929
http://dx.doi.org/10.3803/EnM.2020.777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7937854/
https://www.ncbi.nlm.nih.gov/pubmed/33677929
http://dx.doi.org/10.3803/EnM.2020.777

Ejemplares similares